GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » E10

CrystalGenomics Invites Co (XKRX:083790) E10 : ₩-278.03 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CrystalGenomics Invites Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩-98.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩-278.03 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was -6.00% per year. During the past 5 years, the average E10 Growth Rate was -8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CrystalGenomics Invites Co was -0.90% per year. The lowest was -14.30% per year. And the median was -5.30% per year.

As of today (2024-06-24), CrystalGenomics Invites Co's current stock price is ₩2880.00. CrystalGenomics Invites Co's E10 for the quarter that ended in Mar. 2024 was ₩-278.03. CrystalGenomics Invites Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of CrystalGenomics Invites Co was 2.10. The lowest was 0.00. And the median was 1.24.


CrystalGenomics Invites Co E10 Historical Data

The historical data trend for CrystalGenomics Invites Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co E10 Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -234.71 -234.55 -234.02 -241.39 -279.23

CrystalGenomics Invites Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -242.02 -277.60 -244.22 -279.23 -278.03

Competitive Comparison of CrystalGenomics Invites Co's E10

For the Biotechnology subindustry, CrystalGenomics Invites Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's Shiller PE Ratio falls into.



CrystalGenomics Invites Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CrystalGenomics Invites Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-98/118.8477*118.8477
=-98.000

Current CPI (Mar. 2024) = 118.8477.

CrystalGenomics Invites Co Quarterly Data

per share eps CPI Adj_EPS
201406 -46.708 99.353 -55.873
201409 -61.776 99.608 -73.708
201412 -93.417 99.098 -112.035
201503 -38.673 99.720 -46.091
201506 -45.202 100.050 -53.695
201509 -8.036 100.110 -9.540
201512 -14.063 100.220 -16.677
201603 28.628 100.560 33.834
201606 -9.543 100.790 -11.253
201609 -5.525 101.460 -6.472
201612 -59.349 101.560 -69.451
201703 -37.668 102.850 -43.527
201706 -43.695 102.610 -50.610
201709 10.045 103.490 11.536
201712 -99.444 102.990 -114.756
201803 -28.126 104.100 -32.111
201806 52.821 104.130 60.287
201809 -20.402 105.650 -22.951
201812 119.333 104.350 135.912
201903 18.667 104.490 21.232
201906 -55.333 104.880 -62.702
201909 -70.000 105.200 -79.081
201912 -523.333 105.120 -591.675
202003 -104.667 105.540 -117.865
202006 -21.333 104.870 -24.176
202009 162.667 106.200 182.040
202012 -198.000 105.765 -222.491
202103 8.667 107.357 9.595
202106 3.000 107.579 3.314
202109 -19.000 108.759 -20.762
202112 -240.397 109.676 -260.499
202203 -41.000 111.806 -43.582
202206 -87.000 114.083 -90.634
202209 -57.000 114.831 -58.994
202212 -159.000 115.200 -164.034
202303 -64.000 116.550 -65.262
202306 -473.000 117.140 -479.896
202309 284.000 119.111 283.372
202312 -423.000 118.848 -423.000
202403 -98.000 118.848 -98.000

Add all the adjusted EPS together and divide 10 will get our e10.


CrystalGenomics Invites Co  (XKRX:083790) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of CrystalGenomics Invites Co was 2.10. The lowest was 0.00. And the median was 1.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CrystalGenomics Invites Co E10 Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co (XKRX:083790) Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co (XKRX:083790) Headlines

No Headlines